Trial intelligence / Profile preview

Dopamine Versus Epinephrine for Pediatric Fluid-Refractory Hypotensive Septic Shock

NCT07775001Active, not recruiting

Sponsor
Nishtar Medical University
Start
Feb 2026
Primary completion
Sep 2026
Countries
1
01

Overview

Randomised trial in septic shock comparing Epinephrine Group with Dopamine Group (2 arms). Primary endpoint: Shock Reversal Within 60 Minutes. Started Feb 2026; status: active, not recruiting.

02

Drugs

epinephrinedopamine
03

Conditions

septic shock

Beyond the preview

Go deeper on NCT07775001.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07775001.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call